HKG Equity Snapshot
3759 Weekly Equity Report
Pharmaron Beijing Co., Ltd.
What the company does
Pharmaron Beijing Co., Ltd., together with its subsidiaries, operates as a pharmaceutical research and development service platform in North America, Europe, the Mainland China, Asia, and internationally. It operates through five segments: Laboratory Services; Chemical and Formulation Process Development and Manufacturing Services; Clinical Research Services; Macromolecule and Cell and Gene Therapy Services; and Others. The company offers laboratory chemistry and biological science services, including small molecule chemical drugs, oligonucleotides, peptides, antibodies, antimicrobial agents, antibody-drug conjugates (ADCs), and cell and gene therapy products; small molecule CDMO services, such as API process development and production, material science …
What the weekly tape is saying
3759 closed the latest completed week at 15.52 HKD. The 4-week return is -17.7% and the 12-week return is -16.0%. Trend Signal is inactive, Market Dynamics is -0.97. Setup signature: Risk-first tape with a 14/100 composite read.
A compressed read of the whole setup
The radar blends trend persistence, momentum, Market Dynamics, Relative Strength, volume confirmation, and risk control into one weekly cockpit.
Scoreboard
16-week signal tape
Price, Trend Line, and Fair Value
Weekly price context with the latest close, trend position, Fair Value gap, drawdown, and 52-week range location.
52-week price path
Price map
- Trend Line
- 20.20 HKD
- Vs Trend Line
- -23.2%
- Fair Value
- 16.00 HKD
- Vs Fair Value
- -3.0%
- 52W High
- 30.12 HKD
- 52W Low
- 14.45 HKD
- Drawdown
- -48.5%
- Range Position
- 6.8%
Returns and trend persistence
Return windows separate the latest week from short-term and medium-term follow-through.
Return windows
Trend read
- Active Streak
- 0 weeks
- 52W Active Weeks
- 27
- 52W Active Breadth
- 51.9%
- Sector Scope
- HK Healthcare
- Sector Rank
- 202 of 257
- Sector Percentile
- 21.5%
Sector and industry pulse
Peer breadth helps separate a stock-specific move from a broader group rotation.
HK Healthcare
- Tracked Peers
- 100
- 4W Rank
- 73 of 100
- Avg 1W
- -1.3%
- Avg 4W
- -12.8%
- Trend Breadth
- 6.0%
- Positive MD
- 10.0%
HK Biotechnology
- Tracked Peers
- 76
- 4W Rank
- 37 of 76
- Avg 1W
- -1.6%
- Avg 4W
- -17.5%
- Trend Breadth
- 3.9%
- Positive RS
- 5.3%
Pressure, Relative Strength, and expectation
Market Dynamics and Relative Strength show whether buying pressure and relative leadership are confirming the price move.
Dynamics path
Signal state
- Market Dynamics
- -0.97
- 4W MD Change
- -760963.0%
- Relative Strength
- -23.35
- 4W RS Change
- -110.0%
- Expectation
- Undecided
- Probability
- 49.25%
Participation and confirmation
Volume tells us whether the latest weekly move is being confirmed by unusual participation.
52-week volume profile
Volume map
- Latest Volume
- 33.8M
- 13W Average
- 26.1M
- 52W Average
- 40.2M
- Vs 13W
- 1.3x
- Vs 52W
- 0.8x
Volatility, downside weeks, and return shape
A compact risk profile shows whether the move is steady, volatile, or being driven by sharp one-week jumps.
26-week return distribution
Risk map
- 13W Volatility
- 5.3%
- 52W Volatility
- 7.5%
- Upside Weeks
- 21
- Downside Weeks
- 31
- Downside Breadth
- 59.6%
- Avg Gain / Loss
- 7.3% / -4.8%
Classification, opportunities, risks, and watch points
Top-level read across company classification, constructive evidence, caution points, and the next things that matter.
Classification
- Exchange
- HKG
- Country
- HK
- Sector
- Healthcare
- Industry
- Biotechnology
- Currency
- HKD
- Market Cap
- 31.7B
Opportunity signals
- No strong opportunity cluster is confirmed yet; monitor trend and Market Dynamics.
Risk signals
- Trend Signal is inactive, so price action has not confirmed a constructive regime.
- Price is below the Trend Line, which keeps downside pressure in focus.
- Price is below Fair Value, so the market is still discounting the latest tape.
- Market Dynamics is negative, which weakens the current setup.
- The share remains more than 20% below its 52-week high.
Watch next
- Trend Line remains the key weekly regime level.
- Market Dynamics is the pressure gauge to monitor for confirmation or fade.
- A volume ratio above 1.5x would show stronger participation in the next move.
Recent completed weeks
The latest weekly rows behind the report snapshot.
| Week | Close | Return | Trend | Fair Value | MD | RS | Volume | Signal |
|---|---|---|---|---|---|---|---|---|
| 12 Jun 2026 | 15.52 HKD | -5.8% | 20.20 HKD | 16.00 HKD | -0.97 | -23.35 | 33.8M | Off |
| 5 Jun 2026 | 16.47 HKD | -6.0% | 20.46 HKD | 16.02 HKD | -0.81 | -19.61 | 25.3M | Off |
| 29 May 2026 | 17.52 HKD | -4.8% | 20.71 HKD | 16.03 HKD | -0.57 | -15.20 | 15.4M | Off |
| 22 May 2026 | 18.41 HKD | -2.3% | 20.99 HKD | 16.04 HKD | -0.11 | -12.26 | 20.3M | Off |
| 15 May 2026 | 18.85 HKD | -2.5% | 21.21 HKD | 16.04 HKD | 0.00 | -11.12 | 27.5M | Off |
| 8 May 2026 | 19.34 HKD | -8.1% | 21.36 HKD | 16.05 HKD | 0.06 | -9.96 | 25.9M | Off |
| 1 May 2026 | 21.04 HKD | 2.1% | 21.58 HKD | 16.05 HKD | 0.09 | 0.65 | 39.2M | Off |
| 24 Apr 2026 | 20.60 HKD | -2.9% | 21.86 HKD | 16.05 HKD | -0.05 | -1.80 | 20.0M | Off |
| 17 Apr 2026 | 21.22 HKD | 0.7% | 22.04 HKD | 16.06 HKD | -0.27 | 0.88 | 25.6M | Off |
| 10 Apr 2026 | 21.08 HKD | 0.5% | 22.23 HKD | 16.06 HKD | -0.53 | 1.84 | 20.0M | Off |
| 3 Apr 2026 | 20.98 HKD | 13.2% | 22.32 HKD | 16.08 HKD | -0.63 | 5.07 | 39.2M | Off |
| 27 Mar 2026 | 18.53 HKD | 0.3% | 22.39 HKD | 16.09 HKD | -0.93 | -6.24 | 24.3M | Off |
| 20 Mar 2026 | 18.48 HKD | -6.5% | 22.47 HKD | 16.10 HKD | -0.84 | -7.56 | 22.6M | Off |
| 13 Mar 2026 | 19.76 HKD | 4.0% | 22.58 HKD | 16.15 HKD | -0.84 | -1.77 | 46.7M | Off |